previous compound ID: 265 next compound
InChIKey: BPICBUSOMSTKRF-UHFFFAOYSA-N
SMILES: CC1=C(C(=CC=C1)C)NC2=NCCCS2

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"B Kus" "JW Hanrahan" "DY Thomas" "GW Carlile" "J Goepp" "SD Macknight" "E Matthes" "R Robert" "J Liao" "D Rotin"

chemical graph of compound 265





CID is 5707
synonyms found at PubChem are:
xylazine, 7361-61-7, Rompun, N-(2,6-Dimethylphenyl)-5,6-dihydro-4H-1,3-thiazin-2-amine, Xylazin, Narcoxyl, Xylzin, Xylazinum [INN-Latin], Bayer 1470, Xilazina [INN-Spanish], UNII-2KFG9TP5V8, 4H-1,3-Thiazin-2-amine, N-(2,6-dimethylphenyl)-5,6-dihydro-, BAY 1470, Anased, WH 7286, Xylazine (free base), 2-(2,6-Dimethylanilino)-5,6-dihydro-4H-1,3-thiazine, EINECS 230-902-1, 5,6-Dihydro-2-(2,6-xylidino)-4H-1,3-thiazine, 2KFG9TP5V8, 2,6-Xylidine, N-(5,6-dihydro-4H-1,3-thiazinyl)-, 4H-1,3-Thiazine, 5,6-dihydro-2-(2,6-xylidino)-, MLS000054617, CHEMBL297362, 2-(2,6-Dimethylphenylamino)-4H-5,6-dihydro-1,3-thiazine, BAY-VA-1470, BPICBUSOMSTKRF-UHFFFAOYSA-N, NCGC00016098-07, SMR000061135, CAS-7361-61-7, DSSTox_CID_20643, DSSTox_RID_79519, DSSTox_GSID_40643, Primazine, Rometar, Sedomin, Xilazina, Xylaxine, Xylazinum, 4H-1,3-Thiazine-2-amine, N-(2,6-dimethylphenyl)-5,6-dihydro-, (5,6-Dihydro-4H-[1,3]thiazin-2-yl)-(2,6-dimethyl-phenyl)-amine, 2-[2,6-Dimethylphenylamino]-4H-5,6-dihydroxthiazine, (5,6-Dihydro-4H-[1,3]thiazin-2-yl)-(2,6-dimethyl-phenyl)-amine;N-(2,6-Dimethylphenyl)-5,6-dihydro-4H-1,3-thiazin-2-amine, SR-01000075296, Xylazine [USP:INN:BAN], Xylazine [USAN:INN:BAN], Xylapan, Xylasol, Xylazine(Rompun), xylazine free base, Chanazine (TN), Prestwick_962, Rompun (Salt/Mix), 2-(2,6-Dimethylphenylamino)-5,6-dihydro-4H-thiazine hydrochloride, Xylapan (Salt/Mix), Xylasol (Salt/Mix), Spectrum_001267, Xylazine (USP/INN), Xylazine, >=99%, AC1L1KYH, Opera_ID_1260, Prestwick0_000598, Prestwick1_000598, Prestwick2_000598, Prestwick3_000598, Spectrum2_001448, Spectrum3_001472, Spectrum4_000239, Spectrum5_001250, Lopac-X-1251, D0Y2JI, Lopac0_001249, SCHEMBL15487, BSPBio_000476, BSPBio_003023, GTPL523, KBioGR_000937, KBioSS_001747, KSC638G6L, MLS000881122, DivK1c_000449, SPECTRUM1501200, SPBio_001315, SPBio_002695, BPBio1_000524, ZINC2248, DTXSID3040643, BCBcMAP01_000167, CHEBI:92386, CTK5D8365, HMS501G11, KBio1_000449, KBio2_001747, KBio2_004315, KBio2_006883, KBio3_002523, MolPort-000-869-370, NINDS_000449, HMS1569H18, HMS1921P17, HMS2089E20, HMS2092L07, HMS2096H18, HMS2232F24, HMS3369L20, HMS3713H18, Pharmakon1600-01501200, BCP03045, HY-B0443, KS-00000H9L, Tox21_110303, BDBM50027069, CCG-39193, KM1558, MFCD00057908, NSC758142, SBB038475, 23076-35-9 (mono-hydrochloride), AKOS000115960, Tox21_110303_1, CS-2549, NSC-758142, TRA0042707, IDI1_000449, SMP1_000319, NCGC00016098-01, NCGC00016098-02, NCGC00016098-03, NCGC00016098-04, NCGC00016098-05, NCGC00016098-06, NCGC00016098-08, NCGC00016098-09, NCGC00016098-11, NCGC00038586-02, NCGC00038586-03, NCGC00038586-04, NCGC00038586-05, Xylazine (base and/or unspecified salts), AC-22589, AJ-08151, AK117805, AS-54468, BC252840, SC-47279, BCP0726000235, SBI-0051216.P003, AB2000618, LS-150494, FT-0654963, X5891, D08683, AB00052246-13, AB00052246-15, AB00052246-16, AB00052246_17, AB00052246_18, 361X617, C-46044, L001033, I06-1056, SR-01000075296-4, SR-01000075296-6, BRD-K21565985-001-05-0, BRD-K21565985-001-15-9, (2,6-Dimethyl-phenyl)-[1,3]thiazinan-2-ylidene-amine, (2,6-dimethylphenyl)-4,5-dihydro-6H-1,3-thiazin-2-ylamine, 4H-1,3-Thiazin-2-amine,N-(2,6-dimethylphenyl)-5,6-dihydro-, 4H-1,3-Thiazine-2-amine, N-(2,6-dimethylphenyl)-5,6-dihydro- (9CI), 29335-81-7